BioSpain 2025 starts with new records

Roche gets CE mark for chronic kidney disease algorithm

FDA approves atezolizumab–lurbinectedin for ES-SCLC

Pharma Tariffs: US Government backtracks

Biologics CDMO Rezon Bio leaves stealth mode

Genmab swallows Merus in US$8bn deal